Maria A. Raptis represents clients in connection with the antitrust aspects of litigation, mergers and acquisitions, counseling and criminal matters. Ms. Raptis has represented clients before the Federal Trade Commission and Department of Justice in numerous M&As, including SanDisk in its acquisition by Western Digital, Actavis in its acquisitions of Forest Laboratories and Warner Chilcott; Gilead in its acquisition of Pharmasett; Valeant in its acquisitions of Salix, Medicis, Dermik, Ortho Dermatologics and Biovail; Rite Aid in its acquisition of Envision Pharmaceutical Services; NDS Group in its acquisition by Cisco Systems; Watson in its acquisitions of Actavis and Andrx; and StorageTek in its acquisition by Sun Microsystems. Ms. Raptis’ litigation experience includes defending Actavis in suits brought by the FTC and private plaintiffs relating to “reverse payment” settlements for Androgel, representing Bausch & Lomb in connection with litigation challenging its pricing policies relating to disposable contact lenses, representing Actavis in a multidistrict litigation relating to patent settlements for Lidoderm and defending De Beers in connection with national class actions involving gem diamonds. Ms. Raptis also has represented clients in connection with allegations of price-fixing or other criminal charges, including De Beers in connection with the resolution of a criminal matter relating to industrial diamonds.
766 | Events
On September 3, 2020, the Department of Justice’s Antitrust Division (the DOJ) issued its new Merger Remedies Manual (the Manual), which provides the framework the DOJ will utilize going forward to implement relief in mergers reviewed by its attorneys and economists. The DOJ has updated its (...)
On April 12, the Federal Trade Commission held a hearing to debate the extent to which the FTC should use retrospective reviews to strengthen merger enforcement. This was the latest in the series of hearings on Competition and Consumer Privacy in the 21st Century. The hearing included remarks (...)
The Federal Trade Commission’s (FTC) Bureau of Competition has established a task force dedicated to monitoring competition in U.S. technology markets and taking enforcement actions as warranted. While the remit of the task force largely overlaps with the FTC’s existing enforcement activities, (...)
In a continuation of recent Department of Justice (DOJ) successes challenging mergers, the U.S. District Court for the District of Columbia recently enjoined two more proposed mergers brought and litigated under the Obama administration. Aetna’s $37 billion proposed acquisition of Humana was (...)
On May 10, 2016, Judge Emmet G. Sullivan of the U.S. District Court for the District of Columbia released his highly anticipated decision in the matter of Staples’ acquisition of Office Depot, granting the Federal Trade Commission’s (FTC) request for a preliminary injunction and effectively (...)
This article has been nominated for the 2016 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On September 24, 2015, the U.S. District Court for the Northern District of Ohio denied the Federal Trade Commission’s (FTC) bid to enjoin Steris Corporation (...)